Iterum Therapeutics logo
Iterum Therapeutics ITRM
$ 1.77 0.0%

Quarterly report 2024-Q3
added 11-14-2024

report update icon

Iterum Therapeutics Balance Sheet 2011-2024 | ITRM

Annual Balance Sheet Iterum Therapeutics

2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011

Net Debt

5.75 M -10.7 M -20.1 M 21.9 M 8.62 M -30.5 M -8.48 M -24.8 M - - - - -

Long Term Debt

11.5 M 10.1 M 6.93 M 35.9 M 7.62 M 13.1 M - - - - - - -

Long Term Debt Current

365 K 332 K 464 K 573 K 580 K 1.02 M - - - - - - -

Total Non Current Liabilities

- - - - 15 M 14 M 137 K 30 K - - - - -

Total Current Liabilities

13.5 M 9.06 M 12.9 M 41.7 M 37 M 12.2 M - - - - - - -

Total Liabilities

32.7 M 38.8 M 41.3 M 83.4 M 52 M 26.2 M 7.26 M 4.25 M - - - - -

Deferred Revenue

- - - - - - - - - - - - -

Retained Earnings

-461 M -423 M -378 M -287 M -235 M -132 M -54.7 M -25.3 M - - - - -

Total Assets

26.3 M 66.8 M 91.5 M 32.8 M 25.8 M 97.9 M 46.8 M 26.9 M - - - - -

Cash and Cash Equivalents

6.07 M 21.1 M 27.4 M 14.5 M 4.8 M 44.6 M - - - - - - -

Book Value

-6.4 M 28 M 50.2 M -50.6 M -26.2 M 71.6 M 39.5 M 22.7 M - - - - -

Total Shareholders Equity

-6.4 M 28 M 50.2 M -50.6 M -26.2 M 71.6 M 39.5 M 22.7 M - - - - -

All numbers in USD currency

Quarterly Balance Sheet Iterum Therapeutics

2024-Q3 2024-Q2 2024-Q1 2023-Q3 2023-Q2 2023-Q1 2022-Q4 2022-Q3 2022-Q2 2022-Q1 2021-Q4 2021-Q3 2021-Q2 2021-Q1 2020-Q4 2020-Q3 2020-Q2 2020-Q1 2019-Q4 2019-Q3 2019-Q2 2019-Q1 2018-Q4 2018-Q3 2018-Q2 2018-Q1 2017-Q4 2017-Q3 2017-Q2 2017-Q1 2016-Q4 2016-Q3 2016-Q2 2016-Q1 2015-Q4 2015-Q3 2015-Q2 2015-Q1 2014-Q4 2014-Q3 2014-Q2 2014-Q1 2013-Q4 2013-Q3 2013-Q2 2013-Q1 2012-Q4 2012-Q3 2012-Q2 2012-Q1 2011-Q4 2011-Q3 2011-Q2 2011-Q1

Long Term Debt

11.2 M 11.2 M 11.2 M 12.5 M 11.7 M 10.9 M 10.1 M 9.3 M 8.5 M 7.71 M 6.93 M 6.13 M 5.34 M 6.09 M 22.5 M 22.5 M 22.5 M 22.5 M 7.62 M 7.62 M 7.62 M 7.62 M 13.1 M 13.1 M 13.1 M 13.1 M - - - - - - - - - - - - - - - - - - - - - - - - - - - -

Total Non Current Liabilities

- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

Total Liabilities

27.4 M 25.1 M 25.8 M 36.3 M 43.9 M 39.2 M 38.8 M 39 M 32.8 M 35.4 M 41.3 M 46 M 58.8 M 83.6 M 83.4 M 83.4 M 83.4 M 83.4 M 52 M 52 M 52 M 52 M 26.2 M 26.2 M 26.2 M 26.2 M 7.21 M 7.21 M 7.21 M - - - - - - - - - - - - - - - - - - - - - - - - -

Deferred Revenue

- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

Retained Earnings

-479 M -473 M -468 M -449 M -445 M -433 M -423 M -418 M -389 M -382 M -378 M -374 M -378 M -386 M -287 M -287 M -287 M -287 M -235 M -235 M -235 M -235 M -132 M -132 M -132 M -132 M -54.7 M -54.7 M -54.7 M - - - - - - - - - - - - - - - - - - - - - - - - -

Total Assets

15.9 M 14.2 M 19.6 M 39.7 M 51 M 58.1 M 66.8 M 71.6 M 76.7 M 84.1 M 91.5 M 98.4 M 106 M 115 M 32.8 M 32.8 M 32.8 M 32.8 M 25.8 M 25.8 M 25.8 M 25.8 M 97.9 M 97.9 M 97.9 M 97.9 M 46.8 M 46.8 M 46.8 M - - - - - - - - - - - - - - - - - - - - - - - - -

Cash and Cash Equivalents

13.4 M 4.98 M 7.39 M 4.82 M 13.7 M 16.8 M 21.1 M 20.5 M 9.21 M 31.4 M 27.4 M 36 M 36.6 M 66.6 M 14.5 M 14.5 M 14.5 M 14.5 M 4.8 M 4.8 M 4.8 M 4.8 M 44.6 M 44.6 M 44.6 M 44.6 M 8.48 M 8.48 M 8.48 M - - - - - - - - - - - - - - - - - - - - - - - - -

Book Value

-11.5 M -10.9 M -6.15 M 3.43 M 7.13 M 19 M 28 M 32.5 M 43.9 M 48.6 M 50.2 M 52.4 M 47.2 M 31.5 M -50.6 M -50.6 M -50.6 M -50.6 M -26.2 M -26.2 M -26.2 M -26.2 M 71.6 M 71.6 M 71.6 M 71.6 M 39.6 M 39.6 M 39.6 M - - - - - - - - - - - - - - - - - - - - - - - - -

Total Shareholders Equity

-11.5 M -10.9 M -6.15 M 3.43 M 7.13 M 19 M 28 M 32.5 M 43.9 M 48.6 M 50.2 M 52.4 M 47.2 M 31.5 M 50.6 M -50.6 M -50.6 M -50.6 M -26.2 M -26.2 M -26.2 M -26.2 M 71.6 M 71.6 M 71.6 M 71.6 M 39.5 M 39.5 M 39.5 M - 22.7 M - - - 15 M - - - - - - - - - - - - - - - - - - -

All numbers in USD currency